Home » Topics » BioWorld Science

BioWorld Science
RSS

Suzhou Autopharm Biopharmaceutical synthesizes MAP1LC3B inhibitors

Dec. 20, 2018

U.S. researchers identify new antibacterial compounds

Dec. 20, 2018

Enanta Pharmaceuticals discloses MAP3K5 inhibitors

Dec. 20, 2018

BCL2 coding mutation is associated with venetoclax resistance in CLL

Dec. 20, 2018

Araxes Pharma presents mutant RAS inhibitors

Dec. 20, 2018

Silence Therapeutics adds LP(a)-targeting siRNA medicine SLN-360 to preclinical pipeline

Dec. 20, 2018

PsychENCODE casts light on genetics of psychiatric diseases

Dec. 20, 2018

Sabutoclax as potential new strategy for patients with chemoresistant breast cancer

Dec. 20, 2018

Dexmedetomidine can be used to treat agitation without affecting blood pressure or heart rate

Dec. 20, 2018

Bacterial toxins weaken gut barrier

Dec. 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...